OpenAI launches a model for life sciences and drug discovery
Content Creation Utilities

OpenAI launches a model for life sciences and drug discovery

The company designed the “GPT Rosalind” model, named after twentieth-century British scientist Rosalind Franklin, to support research in biochemistry, drug discovery and translational medicine. Pharmaceutical companies, academic institutions and biotechnology companies have increased demand for tools supported by artificial intelligence to accelerate drug discovery and research. “By supporting evidence synthesis, hypothesis generation, experimental planning and

Scroll to Top